1 | Additional Representation Sheet | 05 May 1989 |
10 | TM-46 | 13 Aug 2012 |
11 | TM-12 | 01 Nov 2012 |
12 | TM-46 | 18 Mar 2013 |
13 | TM-46 | 26 Jun 2014 |
14 | TM-R(RENEWAL OF TRADE MARK) | 22 Apr 2022 |
2 | Certificate | 05 Feb 2003 |
2 | Other Documents | 05 Feb 2003 |
3 | Other Documents | 05 Feb 2003 |
3 | TM-1 | 05 Feb 2003 |
4 | Certificate | 05 Feb 2003 |
4 | Power of Attorney | 05 Feb 2003 |
5 | Power of Attorney | 05 Feb 2003 |
5 | TM-1 | 05 Feb 2003 |
6 | Journal Copy | 05 Feb 2008 |
7 | Additional Representation Sheet | 05 Feb 2008 |
7 | Examination Report | 05 Feb 2008 |
7 | Note Sheet | 05 Feb 2008 |
8 | Examination Report | 05 Feb 2008 |
8 | Note Sheet | 05 Feb 2008 |
9 | Additional Representation Sheet | 05 Feb 2008 |
9 | Examination Report | 05 Feb 2008 |
1 | RENEWAL INTIMATION LETTER | 13405382 | 27 Apr 2022 |
The application for Ometide was made on 05 February 2003.
The trademark applicant for Ometide is SUN PHARMA LABORATORIES.
Ometide is applied in class(es) 5.
Application for Ometide is on Registered stage.
Application Id allotted to Ometide is 1172302.
Trademark agent or attorney for the application is International Trade Marks Bureau.
Ometide filed with the Intellectual property office as a WORD.